Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-22T22:16:46.612Z Has data issue: false hasContentIssue false
  • English
  • Français

Trends in Antimicrobial Susceptibility Patterns Among Inpatient Enterococcal Isolates (1990 to 1999): Implications for Therapeutic Options

Published online by Cambridge University Press:  02 January 2015

Ebbing Lautenbach ,
Jean Baldus Patel ,
Warren B. Bilker  and
Neil O. Fishman
Ebbing Lautenbach
Affiliation:
University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
Jean Baldus Patel
Affiliation:
University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
Warren B. Bilker
Affiliation:
University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
Neil O. Fishman
Affiliation:
University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Infection Control & Hospital Epidemiology , Volume 23 , Issue 8 , August 2002 , pp. 416 - 418
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2002

References

1.Pfaller, MA, Jones, RN, Doern, GV, Sader, HS, Kugler, KC, Beach, ML. Survey of bloodstream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis 1999;33:283–297.Google Scholar
2.Landry, SL, Kaiser, DL, Wenzel, RP. Hospital stay and mortality attributable to nosocomial enterococcal bacteremia: a controlled study. Am J Infect Control 1989;17:323–329.Google Scholar
3.Stosor, V, Peterson, LR, Postelnick, M, Noskin, GA. Enterococcus faecium bacteremia: does vancomycin resistance make a difference? Arch Intern Med 1998;158:522–527.Google Scholar
4.Murray, BE. Vancomycin-resistant enterococcal infections. N Engl J Med 2000;342:710–721.Google Scholar
5.Facklam, RR, Sahm, DF. Enterococcus. In: Murray, PR, Baron, EJ, Phaler, MA, Tenover, FC, Yolken, RH, eds. Manual of Clinical Microbiology, vol. 6. Washington, DC: American Society for Microbiology; 1995: 308–314.Google Scholar
6.National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 5th ed. Wayne, PA: National Committee for Clinical Laboratory Standards; 2000. Approved standard M7-A5.Google Scholar
7.Lautenbach, E, Schuster, MG, Bilker, WB, Brennan, PJ. The role of chloramphenicol in the treatment of bloodstream infection due to vancomycin-resistant Enterococcus. Clin Infect Dis 1998;27:1259–1265.Google Scholar
8.Sahm, DF, Marsilio, MK, Piazza, G. Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the surveillance network database—USA. Clin Infect Dis 1999;29:259–263.Google Scholar
9.Hoge, CW, Adams, J, Buchanan, B, Sears, SD. Enterococcal bacteremia: to treat or not to treat, a reappraisal. Rev Infect Dis 1991; 13:600–605.Google Scholar